mTOR-dependent translation drives tumor infiltrating CD8<sup>+</sup> effector and CD4<sup>+</sup> Treg cells expansion.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34787568.
- Also identified by DOI 10.7554/eLife.69015 and PMC identifier 8598161.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
We performed a systematic analysis of the translation rate of tumor-infiltrating lymphocytes (TILs) and the microenvironment inputs affecting it, both in humans and in mice. Measurement of puromycin incorporation, a proxy of protein synthesis, revealed an increase of translating CD4<sup>+</sup> and CD8<sup>+</sup> cells in tumors, compared to normal tissues. High translation levels are associated with phospho-S6 labeling downstream of mTORC1 activation, whereas low levels correlate with hypoxic areas, in agreement with data showing that T cell receptor stimulation and hypoxia act as translation stimulators and inhibitors, respectively. Additional analyses revealed the specific phenotype of translating TILs. CD8<sup>+</sup> translating cells have enriched expression of IFN-γ and CD-39, and reduced SLAMF6, pointing to a cytotoxic phenotype. CD4<sup>+</sup> translating cells are mostly regulatory T cells (Tregs) with enriched levels of CTLA-4 and Ki67, suggesting an expanding immunosuppressive phenotype. In conclusion, the majority of translationally active TILs is represented by cytotoxic CD8<sup>+</sup> and suppressive CD4<sup>+</sup> Tregs, implying that other subsets may be largely composed by inactive bystanders.
Medical subject headings
- CD4-Positive T-Lymphocytes
- CD8-Positive T-Lymphocytes
- Lymphocytes, Tumor-Infiltrating
- TOR Serine-Threonine Kinases